Kolon TissueGene, Inc is based in South Korea, with the head office in Rockville. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences industry. It was established on June 09, 1999. Kolon TissueGene, Inc currently employs 58 (2025) people. There was a net sales revenue increase of 1.6% reported in Kolon TissueGene, Inc’s latest financial highlights for 2025. During that time, Kolon TissueGene, Inc’s total assets grew by 90.81%. The net profit margin of Kolon TissueGene, Inc decreased by 3067.34% in 2025.
Headquarters
Md, Usa 9713 Key West Ave Suite 300
Rockville; Maryland;
Contact Details: Purchase the Kolon TissueGene, Inc report to view the information.
Website: http://tissuegene.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service